Total Payments
$477,357
2024 Payments
$267,338
Companies
13
Transactions
307
Medicare Patients
6,619
Medicare Billing
$3.6M
Payment Breakdown by Category
Consulting$390,699 (81.8%)
Travel$49,261 (10.3%)
Education$31,400 (6.6%)
Food & Beverage$5,997 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $390,699 | 54 | 81.8% |
| Travel and Lodging | $49,261 | 146 | 10.3% |
| Education | $31,400 | 10 | 6.6% |
| Food and Beverage | $5,997 | 97 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Telix Pharmaceuticals | $440,702 | 274 | $0 (2024) |
| UIH America, Inc. | $35,024 | 3 | $0 (2020) |
| UIH Solutions LLC | $483.10 | 7 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $312.65 | 7 | $0 (2024) |
| United Imaging Healthcare North America LLC | $296.83 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $127.42 | 3 | $0 (2024) |
| Advanced Accelerator Applications | $114.99 | 1 | $0 (2019) |
| Stryker Corporation | $105.95 | 1 | $0 (2017) |
| Lilly USA, LLC | $100.00 | 1 | $0 (2017) |
| Smith & Nephew, Inc. | $33.92 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $267,338 | 129 | Telix Pharmaceuticals ($266,754) |
| 2023 | $143,449 | 141 | Telix Pharmaceuticals ($143,278) |
| 2022 | $30,914 | 21 | Telix Pharmaceuticals ($30,671) |
| 2021 | $25.24 | 1 | UIH Solutions LLC ($25.24) |
| 2020 | $35,102 | 4 | UIH America, Inc. ($35,024) |
| 2019 | $164.25 | 2 | Advanced Accelerator Applications ($114.99) |
| 2018 | $159.20 | 7 | Siemens Medical Solutions USA, Inc. ($83.57) |
| 2017 | $205.95 | 2 | Stryker Corporation ($105.95) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $907.08 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/03/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Food and Beverage | In-kind items and services | $134.15 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 11/29/2024 | United Imaging Healthcare North America LLC | UMI Panorama (Device) | Food and Beverage | Cash or cash equivalent | $96.48 | General |
| Category: Medical Imaging | ||||||
| 11/26/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $407.96 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/23/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $103.60 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/22/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Food and Beverage | In-kind items and services | $35.77 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 11/22/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/14/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $120.22 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/14/2024 | Siemens Medical Solutions USA, Inc. | Biograph Horizon-3R (Device) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 10/31/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $101.50 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/24/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $688.48 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/23/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $743.36 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/23/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $148.48 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/23/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $82.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/23/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $50.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/23/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/17/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/17/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 3,005 | 3,779 | $5.0M | $1.5M |
| 2022 | 10 | 1,851 | 2,587 | $3.7M | $1.3M |
| 2021 | 7 | 1,095 | 1,331 | $1.6M | $547,289 |
| 2020 | 3 | 668 | 788 | $822,761 | $251,187 |
Total Patients
6,619
Total Services
8,485
Medicare Billing
$3.6M
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 405 | 570 | $2.0M | $739,995 | 36.3% |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | Office | 2023 | 93 | 526 | $1.8M | $486,731 | 27.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 341 | 502 | $334,750 | $106,248 | 31.7% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 1,058 | 1,059 | $317,700 | $72,846 | 22.9% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 39 | 52 | $175,822 | $71,055 | 40.4% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 1,058 | 1,059 | $317,700 | $24,171 | 7.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 11 | 11 | $2,728 | $683.76 | 25.1% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 355 | 473 | $1.7M | $615,840 | 37.2% |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | Office | 2022 | 56 | 300 | $789,600 | $238,858 | 30.3% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2022 | 37 | 283 | $498,500 | $189,818 | 38.1% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 299 | 420 | $272,315 | $84,688 | 31.1% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2022 | 22 | 27 | $90,037 | $36,507 | 40.5% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2022 | 493 | 494 | $148,200 | $35,839 | 24.2% |
| A9597 | Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified | Office | 2022 | 11 | 11 | $110,000 | $31,455 | 28.6% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2022 | 484 | 485 | $145,500 | $11,677 | 8.0% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 83 | 83 | $24,900 | $5,470 | 22.0% |
| 79101 | Radioactive drug therapy through a vein | Office | 2022 | 11 | 11 | $3,979 | $1,273 | 32.0% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Office | 2021 | 229 | 332 | $1.2M | $410,750 | 35.6% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2021 | 253 | 378 | $222,042 | $65,431 | 29.5% |
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2021 | 561 | 562 | $168,600 | $38,911 | 23.1% |
| 78816 | Nuclear medicine study with ct imaging whole body | Office | 2021 | 17 | 22 | $65,880 | $28,072 | 42.6% |
| 78306 | Bone and/or joint imaging, whole body | Office | 2021 | 11 | 12 | $8,716 | $2,772 | 31.8% |
| 78431 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress, with concurrently acquired ct transmission scan | Office | 2021 | 13 | 13 | $3,900 | $900.72 | 23.1% |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | Office | 2021 | 11 | 12 | $600.00 | $453.40 | 75.6% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Office | 2020 | 108 | 167 | $604,774 | $199,232 | 32.9% |
About Dr. Jaideep Sohi, M.D
Dr. Jaideep Sohi, M.D is a Nuclear Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356489215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaideep Sohi, M.D has received a total of $477,357 in payments from pharmaceutical and medical device companies, with $267,338 received in 2024. These payments were reported across 307 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($390,699).
As a Medicare-enrolled provider, Sohi has provided services to 6,619 Medicare beneficiaries, totaling 8,485 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Medicine
- Other Specialties Nuclear Radiology
- Location Chicago, IL
- Active Since 02/02/2007
- Last Updated 09/01/2023
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1356489215
Products in Payments
- ILLUCCIX (Drug) $437,852
- uMI 550, uMI 780 (Device) $35,024
- UMI Panorama (Device) $228.86
- uMI (Device) $173.64
- LUTATHERA (Drug) $114.99
- gamma (Device) $105.95
- Biograph Horizon-3R (Device) $102.76
- AMYVID (Drug) $100.00
- uMI 550 (Device) $77.71
- UMI panvivo (Device) $67.97
- Biograph mCT Flow (Device) $64.00
- PLUVICTO (Drug) $58.56
- EVOS (Device) $33.92
- uMR 570 (Device) $25.24
- NEURACEQ (Drug) $24.19
- Axumin (Drug) $17.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Medicine Doctors in Chicago
Ryan Avery, Md, MD
Nuclear Medicine — Payments: $80,351
Nuclear Medicine $80,351
Carla Quijano, M.d, M.D
Nuclear Medicine — Payments: $714.14
Nuclear Medicine $714.14
Dr. Ardita Tali
Nuclear Medicine — Payments: $18.45
Nuclear Medicine $18.45
Stewart Spies, Md, MD
Nuclear Medicine
Nuclear Medicine
Dr. Carlos Bekerman, Md, MD
Nuclear Medicine
Nuclear Medicine
Dr. Nalini Bidani, M.d, M.D
Nuclear Medicine
Nuclear Medicine